FDA approves Medtronic Percept RC with BrainSense adaptive DBS

Medtronic/Percept RC

Medtronic announced FDA approval of Percept RC, the world's first adaptive DBS system with BrainSense technology that records and responds to brain signals. Device automatically adjusts stimulation intensity as symptoms change, personalizing therapy.

• World's first FDA-approved adaptive (closed-loop) DBS system.
• BrainSense technology enables personalized therapy based on brain signals.
• Rechargeable design eliminates replacement surgery.
• Approved for Parkinson's disease and other neurological conditions.